local anaesthesia. agents primarily acting on smooth and skeletal muscles and the respiratory system
Conditions
Interventions
Intervention 1: First group(40 persons) receive lidocaine 1/5% 5cc plus fentanyl 100mg. Intervention 2: Second group (40 persons) receive lidocaine 1/5% 5cc plus ketamin 50mg. Intervention 3: Third gr
Treatment - Drugs
Placebo
First group(40 persons) receive lidocaine 1/5% 5cc plus fentanyl 100mg
Second group (40 persons) receive lidocaine 1/5% 5cc plus ketamin 50mg
Third group (40 persons) lidocaine 1/5% 5cc plus placebo 2cc
Sponsors
Arak University of Medival Sciences
Eligibility
Sex/Gender
Female
Age
20 Years to 45 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: patient candidate curettage; age 20-45 years old; informed written consent for paracervical block. Exclusion criteria: prolonged procedure >20 minutes; failure of block and need to general analgesia; allergy to analgesic substances occurring of any heart diseases.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: 30 and 60 minutes after intervention. Method of measurement: Clinical examination. | — |
Secondary
| Measure | Time frame |
|---|---|
| Drug side effects. Timepoint: 30 and 60 minutes after intervention. Method of measurement: Clinical examination. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMehri Jamilian
Arak University of Medical Sciences
Outcome results
None listed